NEW YORK (GenomeWeb) – Adding its name to a growing list, Chinese firm SeekIn is eyeing a new funding round to support clinical validation and commercialization of a DNA-based blood test for early cancer detection.
NEW YORK (GenomeWeb) – Adding its name to a growing list, Chinese firm SeekIn is eyeing a new funding round to support clinical validation and commercialization of a DNA-based blood test for early cancer detection.